Pain Therapeutics Shares Soar on Pact

November 10, 2005 at 10:16 am · Filed under For Investors

See story here.  King will make an upfront payment of $150 M for Remoxy. I need to do some fact-checking, but this sounds like it could be the largest upfront fee for a Phase 2 product ever. The deal presents a bit of conundrum to Pain Therapeutics investors, who must add the recent poor judgment of King (see my other posts on King’s settlement over Medicaid fraud charges) into the risk equation. The large upfront suggests that Pain Therapeutics certainly has.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • SphereIt
  • TailRank
  • Technorati
Sphere: Related Content

RSS feed for comments on this post · TrackBack URL

Leave a Comment

You must be logged in to post a comment.